A recent survey assessed the factors that adult patients with eczema and caregivers find important regarding clinical trial participation decision-making. When making decisions regarding eczema ...

Despite the need for improved eczema therapies and a rapid increase in available clinical trials, participation remains low. The study researchers said investigational therapies from clinical trials ...

Please provide your email address to receive an email when new articles are posted on . BOSTON — Patients with eczema are increasingly turning to over-the-counter cannabinoid products and physicians ...

One of the most harmful eczema symptoms isn’t visible in the clinic — it’s the sleep patients lose from itching, pain, and bleeding at night. About 43% of people with eczema have sleep problems, ...

For patients with atopic dermatitis (AD), dupilumab maintains its clinical effectiveness up to five years and is discontinued by 23.8% of patients, according to a study published online Aug. 7 in JAMA ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical ...

Eczema can be a burden on the mind as well the body, a new survey shows. People with eczema are more likely to experience depression and anxiety, and it worsens when additional allergic symptoms occur ...

Eczema Expo is an annual four-day event for people with eczema and their loved ones. Held at a new location within the U.S. every summer, Expo provides an opportunity for people impacted by eczema to ...